HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of a homogeneous assay to measure remnant lipoprotein cholesterol.

AbstractBACKGROUND:
Quantification of triglyceride-rich lipoprotein (TRL) remnants is useful for risk assessment of coronary artery disease and the diagnosis of type III hyperlipoproteinemia. Although an immunoseparation procedure for remnant-like particle cholesterol has been evaluated extensively in recent years, available methods for measuring TRL remnants have not achieved wide use in routine laboratory practice, suggesting a need for a homogeneous assay that can measure TRL remnant cholesterol in serum or plasma without pretreatment.
METHODS:
We screened for suitable surfactants that exhibited favorable selectivity toward the VLDL remnant (VLDLR) fraction, including intermediate-density lipoproteins (IDLs). We investigated the principal characteristics of this assay by gel filtration of lipoproteins and their particle size distribution. We developed a simple assay and evaluated its performance with the Hitachi-7170 analyzer.
RESULTS:
Polyoxyethylene-polyoxybutylene block copolymer (POE-POB) exhibited favorable selectivity toward VLDLR and IDL fractions. POE-POB removed apolipoprotein (apo) E and apo C-III from IDL particles in the presence of cholesterol esterase (CHER), and the particle size distribution of IDLs became smaller after the reaction. These results revealed that IDL particles are specifically modified in the presence of CHER and POE-POB, making their component cholesterol available for enzymatic assay. Addition of phospholipase D improved the reactivity toward chylomicron remnants (CMRs). We found a high correlation [y = 1.018x- 0.01 mmol/L, r = 0.962 (n = 160)] between the proposed assay and the immunoseparation assay in serum from healthy individuals.
CONCLUSION:
The homogeneous assay described in this report can measure TRL remnant cholesterol, including CMRs, VLDLRs, and IDLs, with high sensitivity and specificity.
AuthorsKazuhito Miyauchi, Norihiko Kayahara, Masato Ishigami, Hideyuki Kuwata, Hideharu Mori, Hiroyuki Sugiuchi, Tetsumi Irie, Akira Tanaka, Shizuya Yamashita, Taku Yamamura
JournalClinical chemistry (Clin Chem) Vol. 53 Issue 12 Pg. 2128-35 (Dec 2007) ISSN: 0009-9147 [Print] England
PMID17901111 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cholesterol, VLDL
  • Chylomicron Remnants
  • Epoxy Compounds
  • Indicators and Reagents
  • Lipoproteins
  • Lipoproteins, IDL
  • Surface-Active Agents
  • Triglycerides
  • remnant-like particle cholesterol
  • poly(ethylene oxide)-poly(butylene oxide) copolymer
  • Polyethylene Glycols
  • Cholesterol
  • Phospholipase D
Topics
  • Autoanalysis
  • Cholesterol (blood)
  • Cholesterol, VLDL (blood)
  • Chromatography, Gel
  • Chylomicron Remnants (blood)
  • Epoxy Compounds
  • Humans
  • Hyperlipoproteinemia Type III (metabolism)
  • Indicators and Reagents
  • Lipoproteins (blood)
  • Lipoproteins, IDL (blood)
  • Phospholipase D
  • Polyethylene Glycols
  • Surface-Active Agents
  • Triglycerides (blood)
  • Ultracentrifugation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: